| P50 | author | Masakazu Toi | Q92741931 |
| | Kari Alitalo | Q6370341 |
| | Jonathan P. Sleeman | Q42798978 |
| P2093 | author name string | Hermann-Josef Gröne | |
| | Hiroko Bando | |
| | Herbert A Weich | |
| | Bence Sipos | |
| | Maren Brokelmann | |
| P2860 | cites work | Missense mutations interfere with VEGFR-3 signalling in primary lymphoedema | Q22254202 |
| | Isolated lymphatic endothelial cells transduce growth, survival and migratory signals via the VEGF-C/D receptor VEGFR-3 | Q24291630 |
| | Congenital hereditary lymphedema caused by a mutation that inactivates VEGFR3 tyrosine kinase | Q24538742 |
| | Lymphatic endothelium: morphological, molecular and functional properties | Q24672687 |
| | Vascular endothelial growth factor (VEGF)-C signaling through FLT-4 (VEGFR-3) mediates leukemic cell proliferation, survival, and resistance to chemotherapy | Q28204981 |
| | Hyperplasia of lymphatic vessels in VEGF-C transgenic mice | Q28238886 |
| | VEGF and VEGF-C: specific induction of angiogenesis and lymphangiogenesis in the differentiated avian chorioallantoic membrane | Q28245526 |
| | Characterization of murine Flt4 ligand/VEGF-C | Q28245632 |
| | VEGFs, receptors and angiogenesis | Q33644265 |
| | Markers for the lymphatic endothelium: in search of the holy grail? | Q34398711 |
| | Clinical significance of vascular endothelial growth factor C and vascular endothelial growth factor receptor 3 in patients with nonsmall cell lung carcinoma | Q35041319 |
| | Signalling via vascular endothelial growth factor receptor-3 is sufficient for lymphangiogenesis in transgenic mice | Q39714957 |
| | Clinical importance of the determination of tumor angiogenesis in breast carcinoma: much more than a new prognostic tool | Q40398499 |
| | Endothelial receptor tyrosine kinases involved in angiogenesis. | Q40400431 |
| | Signaling angiogenesis and lymphangiogenesis | Q41750930 |
| | Vascular endothelial growth factor is a potential tumour angiogenesis factor in human gliomas in vivo. | Q44393459 |
| | Differential binding characteristics and cellular inhibition by soluble VEGF receptors 1 and 2. | Q47952455 |
| | Quantification of vascular endothelial growth factor-C (VEGF-C) by a novel ELISA. | Q51022937 |
| | VEGF-C and VEGF-D expression in neuroendocrine cells and their receptor, VEGFR-3, in fenestrated blood vessels in human tissues | Q57382249 |
| | The Vascular Endothelial Growth Factor Receptor Flt-1 Mediates Biological Activities | Q59261168 |
| P433 | issue | 2 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 184-191 | |
| P577 | publication date | 2004-08-01 | |
| P1433 | published in | International Journal of Cancer | Q332492 |
| P1476 | title | Immunodetection and quantification of vascular endothelial growth factor receptor-3 in human malignant tumor tissues | |
| P478 | volume | 111 | |